Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Insulin Resistance: early-phase trial registry
32 of 122 indexed Insulin Resistance trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #100 of 28,707 conditions by registered trial count.
122 US clinical trials · 32 currently recruiting · #100 of 28,707 conditions by registered trial count
Insulin Resistance: 122 US clinical trials tracked, 32 recruiting.
Insulin Resistance is the subject of 122 registered US clinical trials on ClinicalTrials.gov, 32 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Washington University School of Medicine, running 7 of these trials.
Enrollment posture brief
Registry condition insulin-resistance
OPEN 32 | RECR 26% | LATE 10 | EARLY 22 | RANK #100 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Attention Deficit Hyperactivity Disorder (ADHD) (26% recruiting · 19 trials)
Insulin Resistance lists 32 open slots (26% of 122 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Insulin Resistance on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Insulin Resistance is recruiting below its size-band peers.
32 of 122 indexed trials (26.2%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Insulin Resistance trials is spread across many organizations.
Washington University School of Medicine accounts for 7 of 122 trials (5.7%). 72 distinct sponsors appear on at least one study for this condition label.
-
Most Insulin Resistance trials plan to enrol fewer than 100 people.
Median target enrolment is 53 among the 121 trials that report a genuine target (sentinel values excluded). 92 of those (76%) plan for fewer than 100 participants.
-
Insulin Resistance research is mostly interventional.
102 interventional and 20 observational studies make up this index (83.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
122 total, page 3 of 3
Resveratrol and the Metabolic Syndrome
Rockefeller University
NCT01714102
Relative Sarcopenia and Cardiometabolic Risk in Young Adults With Obesity
Massachusetts General Hospital
NCT04195061
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study
Indiana University
NCT00871234
Mitochondrial Methylation in Type 2 Diabetes
University of Arizona
NCT04126551
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)
Pennington Biomedical Research Center
NCT02697201
Carnitine and Liver Mitochondria Fatty Acid Processing
Pennington Biomedical Research Center
NCT03193125
Insulin Resistance in Adolescents
University of Wisconsin, Madison
NCT04089332
Relation of Obesity With Frequency of Meals (MST 0557)
Rockefeller University
NCT00229255
Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes.
University of Chicago
NCT00720889
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
Beth Israel Deaconess Medical Center
NCT00004419
Acute Exercise on Brain Insulin Sensitivity
Rutgers, The State University of New Jersey
NCT05853913
Production of Free Fatty Acids From Blood Triglycerides
Mayo Clinic
NCT00911482
Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents
Yale University
NCT01901978
Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes
Nick Giannoukakis, PhD
NCT02597101
Effects of Sleep Duration and Architecture on Insulin Sensitivity
University of California, San Francisco
NCT01396941
Low Dose Fat-Induced Insulin Resistance
University of Pennsylvania
NCT03479671
Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
Pennington Biomedical Research Center
NCT01872533
Comparison of Time-Restricted Feeding Versus Grazing
Pennington Biomedical Research Center
NCT01895179
Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health
Washington University School of Medicine
NCT02706288
A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production
Harbor Therapeutics
NCT00991107
Novel Therapies for Metabolic Complications of Lipodystrophies
University of Texas Southwestern Medical Center
NCT00457938
Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
University of Colorado, Denver
NCT00364221
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 7 |
| Phase 3 | 2 |
| Phase 4 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Insulin Resistance records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Insulin Resistance trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Insulin Resistance page
122 registered trials, 32 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 32 Insulin Resistance trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Washington University School of Medicine sponsors the most Insulin Resistance trials on record, review their full trial history before evaluating a specific study. See Washington University School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insulin Resistance condition card totals 122 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.